Events

An invitation to the nutraceutical industry for a networking function at the University of Auckland

Date: Tuesday 4th December 2012
Time: 4:30pm – 6.00pm networking forum including tours of the facilities
Venue: Reception lounge, School of Biological Sciences, Thomas Building, 3A Symonds St, Auckland.
Parking: Under the Owen G Glenn Building, 12 Grafton Rd

Food and health is one of the thematic priority areas for the University of Auckland and we would like to invite you to this networking event where you will:

  • Increase your network with other players in the nutraceutical sector (company and University staff) over drinks and nibbles.
  • Learn how you can support your products with cutting-edge science by accessing the University’s wide-ranging expertise, advanced facilities for research and development, analytical systems, bioactivity and bioavailability assays, and human clinical trials for new functional foods.
  • Join us on a tour around through the facilities of the School of Biological Sciences and the Institute for Innovation in Biotechnology.
  • Understand through a brief presentation how you can join this vibrant environment and partner with the University through contract research, secondments of company staff and/or co-location of an R&D team.

Who will attend?

Representatives from companies developing and manufacturing nutraceutical products, functional foods, supplements and/or ingredients, and representatives from public sector organisations engaged in this industry, are cordially invited to this event. University staff active in this sector and wishing to engage with the industry are kindly invited to attend.

Where is it?

Institute for Innovation in Biotechnology where companies can second staff or co-locate an R&D team to gain full access to the expertise, specialist facilities and hi-tech equipment in the University’s School of Biological Sciences. Opportunities exist to collaborate with relevant academic groups University-wide, including human nutrition trials and clinical trials.

All welcome. RSVPs to Joerg Kistler, Director IIB, for organisational purposes would be greatly appreciated. Please email your name and company name as you would like it to appear on the name tags to j.kistler@auckland.ac.nz.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by NZTE

Date: Friday 19th October, 2012
Time: Presentation 4:30pm, followed by drinks and nibbles
Venue: SBS Reception Lounge (Common Room)

Title: Beyond the ‘Three B’s’(x2?)
Presented by Wayne Leech, Head of Centre for Innovation & Development, Bayer NZ

We know that Bayer Bought Bomac, but did that give the Bomac owners the Boat, the Bach and the BMW? And what has happened to Bomac? Our guest speaker for the October forum is Wayne Leech, Head of Centre for Innovation & Development, Bayer NZ and former CEO of Bomac. He will provide insight to the former three B’s – no promises about the latter – from his perspective of running a New Zealand company that is now an important element of a multinational corporate.

Bayer’s acquisition of Bomac in 2011 brought together two very different business cultures. It was also a striking example of the value of animal health to NZ’s bio industry. The acquisition process itself is of great interest. While Bomac was NZ’s largest privately owned animal healthcare company with 200 staff and 290 products being sold in over 60 countries, it was dwarfed by Bayer. Bayer was a multinational with over 108,000 staff, generating a revenue of 31.2 billion Euros. How was Bomac valued and what is its new role?

Please join us to hear Wayne Leech tell the Bomac to Bayer story and provide insight to the role and operation of this Bayer NZ company.

All welcome. RSVPs to Margot Bethell for organizational purposes would be greatly appreciated. Please email director@bioscienterprise.ac.nz or phone (09) 373 7599 ext 89625 or 0274 305 758.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by NZTE

Date: Friday 14th September, 2012
Time: Presentation 4:30pm, followed by drinks and nibbles
Venue: SBS Reception Lounge (Common Room)

Title: Bowling You Over
Presented by David Anstice, Business Development Manager for the Food Bowl and Sector Specialist, Food and Beverage, with ATEED

The Food Bowl at Manukau, with its 2000 square meters of space and processing equipment aimed at supporting companies moving from lab-bench ‘R’ and into the ‘D’ phase, should be of great interest to the bioscience industry. Already utilised by Plant & Food and several SME’s in this sector, this is an exciting entity.

The Food Bowl is a model of infrastructure, skilled support and facilities that encourages strategic sector clustering.

It is already identified as an iconic company/organisation that will be included in the new Advanced Technology Institute (ATI).

Several millions of dollars of state-of-the-art high tech equipment allows for innovative approaches throughout the processing of many forms of food and beverage produced for a variety of functions.

Confidentiality for the companies utilising the Food Bowl is assured by the presence of 4 totally independent processing suites, complemented by private carparking. Each suite is available for as short a time as one day.

Flexibility and wide ranging capability is assured by complementing the several large fixed pieces of high tech equipment, such as the High Pressure Pasteurization machine, with over 200 pieces of mobile ancillary pieces of equipment.

GMP accreditation allows companies in the health space to produce product for clinical trials.

FSP (Food Safety Programme) and RMP (Risk Management Programme) registration allows companies to assess the issues associated with scale up of production under regulated conditions. Together with the ability to produce small scale commercial quantities, companies have the potential to significantly increase their business development options.

David Anstice, Business Development Manager for the Food Bowl and Sector Specialist, Food and Beverage, with ATEED will be our guest speaker at this month’s forum.

You are warmly invited to take the opportunity to be ‘bowled over’ as David explains how the Food Bowl is increasing NZ’s capability and productivity in the F&B sector and to consider the possibilities this model has for the wider bioscience industry.

All welcome. RSVPs to Margot Bethell for organizational purposes would be greatly appreciated. Please email director@bioscienterprise.ac.nz or phone (09) 923 9625 or 0274 305 758.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by NZTE

Date: Friday 17th August 2012
Time: Presentation – 4.30 pm.
Followed by drinks and nibbles
Venue: Reception Lounge, Main entrance of Thomas Building, 3 Symonds Street.

NZTE – At Your Service

You may have noticed the odd change or two taking place within/between / around the government departments and organisations that have traditionally supported the bioscience industry? New Zealand Trade & Enterprise has not been spared from these events and is now operating under quite a new ‘look’. The industry sectors are gone and companies now have the opportunity to engage under programmes and projects. We thought it would be timely to become better aquainted with the possibilities.

Our guest speaker, Hans Frauenlob, is NZTE’s General Manager, Products and Services. In this role he leads the design and delivery of the Beachheads Programme which many of you will be familiar with. You may not be so familiar with two other programmes that NZTE have identified as being strategically important to building industry capability that Hans also leads – Better By Design and Lean Business.

Hans’ presentation will look at how NZTE delivers the current government policy and NZTE’s relationship with the newly formed MoBIE and ATI. As well as the programmes he leads,Hans will also consider other services offered one-on-one to companies such research into market intelligence. He will also describe the significance of the eight High Impact programmes such as Health, Agribusiness and China and how they support the life science industry.

You are warmly invited to take the opportunity to join us and learn more about how to access NZTE’s products and services from General Manager Hans Frauenlob.

All welcome. RSVPs to Margot Bethell for organizational purposes would be greatly appreciated. Please email director@bioscienterprise.ac.nz or phone (09) 923 9625 or 0274 305 758.

Public car parking is available nearby under the U of A’s Business School, the Owen G Glenn Building, in Grafton Rd. (see attached map). There is also limited parking available in Princes St.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by NZTE

Date: Friday 13th July, 2012
Time: Presentation 4:30pm, followed by drinks and nibbles
Venue: SBS Reception Lounge (Common Room)

Title: North to South, West to East – A Global Experience
Presented by Dr Suzanne Bertran, CE of NZBIO

Our guest speaker, Dr Suzanne Bertrand, has travelled south from the north end of the Northern Hemisphere and then half way round the world to live and work in New Zealand. On the way there was the US, China, Nth Africa....

Suzanne obtained her PhD in molecular biology at Laval University in Québec City and is now CE of NZBIO. In-between she has worked in both the public and private sector of the bio-industry as a research scientist, a consultant, a team manager and project leader, a start-up founder and CEO. In this presentation, Suzanne will focus on her experiences in establishing successful bio-industry operations in cultures vastly different to her own.

Suzanne was responsible for development projects in both Tunisia and China, where she lived in the Gansu province. Her projects involved many of the areas of bioscience around sustainability of food and the environment where NZ has much to offer globally, including soil analysis, water quality and plant physiology. Her experiences, though, translate even more broadly.

Suzanne experienced both frustration and great satisfaction as she learnt to operate in different cultures and different political systems and meet a range of expectations. Her ‘learning experiences’ were many. Suzanne learnt the importance of distinguishing between direct translation and developing a mutual understanding. She had the pleasure of overseeing the setting up of laboratories and systems entirely reliant on imported equipment evolving to those that were self-sufficient. She dealt with the obstacles to bringing western experts beyond the major cities to travel throughout the country to where they were needed. The list goes on..

Please join us to share Dr Suzanne Bertrand’s insights to the rewards and challenges faced by a westerner living and working in the bioscience sector in Nth Africa and China.

All welcome. RSVPs to Margot Bethell for organizational purposes would be greatly appreciated. Please email mailto:director@bioscienterprise.ac.nz or phone (09) 373 7599 ext 89625 or 0274 305 758.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by NZTE

Date: Friday 18th May, 2012
Time: Presentation 4:30pm, followed by drinks and nibbles
Venue: SBS Reception Lounge (Common Room)

Title: Having The Stomach to Succeed
Presented by Dr Brian Ward, CEO of Wellington start-up Mesynthes

Having a promising technology – even a very promising technology – is one thing; going out on a limb (or an organ) to develop it is another. Choosing the best pathway to success is often a dilemma.

Dr Brian Ward, CEO of Wellington start-up Mesynthes, left the relative security of his role as the inaugural CEO of NZBIO just over 4 years ago in order to clean sheep stomachs. A lot has happened since then.

That cleaning is now a proprietary process that purifies and sterilizes the tissue to produce Endoform – an extracellular matrix containing structural proteins, adhesive proteins, glycosaminoglycans and growth factors. The resulting biomaterial is an exciting example of convergence of medical device and therapeutic technologies. Targeting the soft-tissue regeneration market (in excess of US$6 billion), it demonstrates quantitatively superior outcomes in vascularisation and rate and quality of repair. Mesynthes aims for Endoform to be the ECM platform of choice for regenerative medicine.

The lead product, Endoform Dermal Template or EDT, is used in chronic wound healing. With it, Mesynthes has completed very positive clinical trials, has achieved FDA 510k regulatory approval, has secured agreement with a multinational for distribution in Nth. America and agreement with another multinational in Europe for the development of a further wound care product.

Mesynthes has also established a certified cGMP facility with the capacity to meet the demand for commercial product of EDT for the next three years.

Two second generation products – Endoform Regenerative Template or ERT and Endoform Infection Control or EIC – are being developed. A 510k FDA application has been filed for ERT and EIC has achieved proof-of-concept.

With its products protected through patents, regulatory compliance and trade secrets as well as established partnerships with multinationals but also the potential to sell directly to niche markets, Mesynthes must decide on the best way forward from here.

Please join us as Dr Brian Ward’s discusses the development of a business strategy for taking a specialised NZ bioscience company to the global market.

All welcome. RSVPs to Margot Bethell for organizational purposes would be greatly appreciated. Please email director@bioscienterprise.ac.nz or phone (09) 923 9625 or 0274 305 758.

Public car parking is available nearby under the U of A’s Business School, the Owen G Glenn Building, in Grafton Rd. There is also limited parking available in Princes St.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by NZTE

Date: Friday 27th April, 2012
Time: Presentation 4:30pm, followed by drinks and nibbles
Venue: SBS Reception Lounge (Common Room)

Title: Channelling Success
Presented by Brent Ogilvie, Pacific Channel’s founder and CEO.

As much as it sometimes seems that the bioindustry needs a little supernatural help, this is more of the guiding in the right direction type of channelling!

Pacific Channel
is now into its 7th year of providing support for young innovative life science companies. These companies range from bioactives and functional foods to biofuels; agbio and environmental technologies to diagnostics.

Pacific Channel has founded 7 companies with scientists to develop and commercialise novel technologies. Sourcing finance, providing guidance, management and governance as needed, Pacific Channel provides valuable survival tools to companies crossing the ‘valley of death’. They have placed investment of $0.5m to $5m for 14 ventures in 22 rounds totalling over NZD20m. This includes Pacific Channel’s role since mid-2008 as a seed and early stage investor in partnership with the NZ Venture Investment Fund, and a number of wealthy co-investors.

Pacific Channel’s founder and CEO, Brent Ogilvie, together with his colleagues Dr Robert Feldman and Mitali Purohit, will share their insight into what drives investment into start-up and early stage life science companies. Pacific Channel has led 20-33% of all seed & early stage NZ life science deals over the last 5 years and they will focus especially on what attracts both local and international capital to NZ companies.

Please join us as Pacific Channel shares its experience of the characteristics and attributes of companies that lead to investment and success.

All welcome. RSVPs to Margot Bethell for organizational purposes would be greatly appreciated. Please email director@bioscienterprise.ac.nz or phone (09) 373 7599 ext 89625 or 0274 305 758.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by NZTE

Date: Friday 23th March, 2012
Time: Presentation 5pm, followed by drinks and nibbles
Venue: SBS Reception Lounge (Common Room)

Title: To List, or Not To List, That is the Question
Presented by David Blake, co-founder and co-editor of Bioshares.

Listing on the stock exchange is one of the key options for companies wanting financial security. But how to know when an IPO will be successful – and how to get to that point? Guest speaker David Blake, co-founder and co-editor of Bioshares will speak about the imperative for companies to have a well developed capital career plan from their inception if they are to maximise the probability of their success. Such an approach impacts on all aspects of the company; their business strategy, product development and management composition.

During his presentation, David will analyse the pathway to success for two listed Australian companies – Acrux (a drug delivery company that completed a $300M license deal) and Mesoblast (a $2B company based on adult stem cells).

Many of you will be familiar with Bioshares as Australia’s leading biotech stock report, delivering independent investment research to investors on ASX listed biotech, pharmaceutical and healthcare companies. It also organises a highly regarded Biotechnology summit each year designed to inform the investment sector and to encourage investment in the life science industry. Last year Bioshares had support from NZTE to hold this summit in New Zealand (Queenstown), attracting many international investors. The summit will be held in Queenstown again this year.

Please join us to discuss with David the mind set and practices he believes biocompanies need to adopt to maximise financial and investment success.

All welcome. RSVPs to Margot Bethell for organizational purposes would be greatly appreciated. Please email director@bioscienterprise.ac.nz or phone (09) 373 7599 ext 89625 or 0274 305 758.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by NZTE

Date: Friday 24th February, 2012
Time: Presentation 4.30pm, followed by drinks and nibbles
Venue: SBS Reception Lounge (Common Room)

Title: Commercialisation Strategies for Innovating Firms
Presented by Associate Professor Simon Wakeman.

Associate Professor Simon Wakeman has been in New Zealand for the past two months applying his extensive knowledge of commercialisation in the US (by analysing over 1400 products) to issues for NZ companies. Simon describes his presentation as follows: A major issue for start-up firms is how to access the product development and marketing capabilities necessary to get an innovation to market. The decision whether and when to partner with an established firm not only influences the success of the innovation, but also how much value the innovator captures. However, there is considerable variation even within partnership arrangements. This seminar will outline the different arrangements used by biopharmaceutical firms to commercialize their innovation, focusing specifically on the choice between straight licensing arrangements and co-development arrangements. It will present data from the US biotech industry on what drives firms into one arrangement or the other, and how the choice affects their subsequent commercialization success.

Simon_Wakeman

Simon Wakeman is Associate Professor at the European School of Management and Technology (ESMT) in Berlin, Germany. He holds a PhD from the University of California at Berkeley, and prior to joining ESMT was a Research Fellow at the Center for Law & Biosciences at Stanford Law School. His research examines firm strategy for commercializing innovation, with a particular focus on the role that contractual arrangements and intellectual property rights play in that strategy. At ESMT he teaches courses on Business Strategy and Capturing Value from Innovation in the Full-Time MBA, Executive MBA, and Executive Education programs

You are warmly invited to join us to discuss Simon’s insights on how New Zealand companies can best capture value around innovation.

All welcome. RSVPs to Margot Bethell for organisational purposes would be greatly appreciated. Please email director@bioscienterprise.ac.nz or phone (09) 923 9625 or 0274 305 758.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by NZTE

Date: Friday 9th December 2011
Time: Presentation – 4.30pm. Followed by drinks and nibbles
Venue: Reception Lounge, Main entrance of Thomas Building, 3 Symonds Street.
Speaker: Phil O’Reilly’s, Chief Executive of BusinessNZ
Title: Celebrating ‘Belgium’ (?!?....)

The last Bioscience Enterprise forum for 2011 is not to be missed. We will be celebrating.

We will be celebrating Phil O’Reilly’s vision of an economically vibrant New Zealand. From his position as Chief Executive of BusinessNZ, Phil’s stimulating presentation will look at what is needed to take the results of NZ's innovative skills into the global market.

We will be celebrating the 5th birthday of the MBioEnt qualification and the success of its ‘bilingual’ graduates in creating a bridge between the worlds of science and business.

We will be celebrating the successful completion of this year’s MBE theses as the 2011 interns now prepare to make their mark in the bioscience ecosystem.

We will be celebrating – and acknowledging – the wonderful support the programme has enjoyed from so many people across the bioindustry.

We will celebrate the end of the formalities with the eagerly anticipated, if somewhat inexpert, sabre champagne.

We would love you to join us to mark this occasion - and to debate how successfully the MBioEnt programme has contributed to Phil O’Reilly’s ‘Belgium’.

All welcome. RSVPs to Margot Bethell for organisational purposes would be greatly appreciated. Please email director@bioscienterprise.ac.nz or phone (09) 373 7599 ext. 89625 or 0274 305 758.